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ABSTRACT 
 
Antioxidant Effects of Phytochemicals in Texas Red Wine on Breast Cancer Cells. 
(April 2009) 
 
Alexandra Elizabeth Hagood 
Department of Nutrition and Food Science 
Texas A&M University 
 
Research Advisor: Dr. Susanne Talcott 
Department of Food and Nutritional Science 
 
The anti-cancer effects of wine have been greatly studied, mainly on Vitis Vinifera 
grapes.  There is a lack of information about the effects of Texas wines in particular, and 
it was the goal of this study to investigate two of these wines (one Syrah and one Port).  
Antioxidant capacity of the wines was determined using an ORAC assay.  Effects on cell 
proliferation and reactive oxygen species were tested on invasive estrogen-receptor 
negative breast cancer cells (MDA-MB-231).  These cells were treated with extract 
concentrations from 12.5-200 µg GAE/mL diluted in DMSO (up to ~0.2% volume in 
medium).  When treated with 50 µg GAE/mL Syrah wine extract, cell proliferation was 
decreased to 59% of the control, and at 200 µg GAE/mL cell proliferation was decreased 
to 41%.  When treated with 50 µg GAE/mL Port wine extract, cell proliferation 
decreased to 54% at and to an impressive 18% at 200 µg GAE/mL.  When treated with 
Syrah wine extract, the generation of reactive oxygen species decreased in a dose-
dependant manner from 71.8% at 12.5 µg GAE/mL to 27.2% of the control at 200 µg 
GAE/mL and still 67% at 12.5 µg GAE/mL.  The Port wine extract was less effective at 
  iv 
low concentrations (decrease in ROS to 85.8% at 12.5 µg GAE/mL).  At higher 
concentrations, results were similar to that of the Syrah wine extract.  Results were 
conflicting as the Syrah had a greater effect on the inhibition of generating reactive 
oxygen species while the Port had a greater effect of cell growth inhibition.  This study 
will lead to further, more detailed studies identifying isolated polyphenolics from wines 
causing the beneficial effect, the mechanisms behind their effects and possibly, how 
these compounds could be utilized to prevent or slow the progression of this invasive 
cancer. 
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NOMENCLATURE 
 
AOX Antioxidant 
DMSO Dimethylsulfoxide 
FBS Fetal Bovine Serum 
GAE Gallic Acid Equivalents 
MDA-MB-231  Estrogen Receptor Negative Late Stage Breast Cancer Cell 
Line 
ORAC Oxygen Radical Absorbance Capacity Assay 
PBS Phosphate Buffer Solution 
ppm Parts per Million  
ROS Reactive Oxygen Species 
TTX Treatment 
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CHAPTER I 
INTRODUCTION 
 
Cancer is the second leading cause of death in America, second to heart disease, as of 
2005 (1).  A trend was noticed, in that the occurrence of cancer was much lower in those 
who ate larger quantities of fruit and vegetables in their diet (2).  Further investigation 
pointed to phytochemicals in many of these fruits and vegetables having antioxidant 
properties and that they help to prevent and/or slow the progression of many types of 
cancer cells.  Several in vitro and in vivo studies have demonstrated the antioxidant and 
anti-inflammatory effect of phytochemicals relevant to several types of cancer (3-12).   
 
This project proposes to study two Texas-specific winegrape varieties and the anti-
cancer effects of their polyphenolics by measuring basic antioxidant, cell death and anti-
inflammatory biomarkers in breast cancer cells.  Before discussing the specifics of this 
project, it will be useful to give a general background of breast cancer, its risk factors 
and development, and why it is thought these phytochemicals from winegrapes may play 
a role in the future of cancer prevention and treatment. 
 
 
_______________ 
This thesis follows the style of Molecular and Cellular Biochemistry. 
  2 
Breast cancer 
Among women in the United States, breast cancer is the most common form of cancer 
and is second only to lung cancer as the leading cause of cancer death.  It has been 
estimated that 182,460 women will be diagnosed with invasive breast cancer and 40,480 
will die of it in 2008 (13).  Of those with invasive breast cancer, 5-10% of cases are 
known to be due to one of the most proven risk factors: heredity (12).  
 
Unfortunately, heredity, like other known factors including genetics, age, race, 
menarche, breast tissue density, having had no children, personal (13) and family 
medical history (13, 14), late parity (or age of first full term pregnancy) (2, 14) and 
education (14) are unalterable.  However, other risk factors such as using birth control 
pills (13), forgoing breast feeding, low levels of physical activity, obesity (13, 14), poor 
diet (2, 14) and alcohol consumption (13-15) are lifestyle behaviors that can easily be 
adjusted to reduce risk.  Additionally, treatments such as post-menopausal hormone 
therapy, radiation and DES (diethylstilbestrol) are risk factors.  It should be noted that 
while breast cancer occurs primarily in women, men can develop it as well (13).  
 
The development of breast cancer begins in the cells of the breast tissue: cells that line 
the ducts of the mammary gland or cells in the lobes of the breast are damaged and over 
many stages develop into a malignant tumor (13).  Hormones play a role in breast cancer 
risk and some hypothesize that alcohol (not distinguishing between beer, liquor and 
wine) intake increases amounts of certain circulating sex hormones and affects a 
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person’s risk (13, 15).  Most early-stage breast cancers are estrogen-receptor (ER)-
positive and respond to endocrine treatment with antiestrogens.  However, later-stage 
breast cancers are ER-negative and more aggressive, requiring treatment with cytotoxic 
drugs.  Since antiestrogens do not affect these cases, another property of the cancer must 
be exploited: reactive oxygen species (ROS).  ROS are small molecules or ions with a 
free electron and can be oxygen ions or free radicals, which are produced by the 
mitochondria during energy metabolism (8).  It has been learned that breast cancer 
initially begins with ROS-induced damage to a cell’s DNA (4, 11, 12) by causing lesions 
on the DNA that change a normal breast cell into a malignant one.  Healthy human cells 
are equipped with repair mechanisms to rapidly mend any DNA damage.  One study 
induced oxidative damage in different lines of breast cancer cells with hydrogen 
peroxide (H2O2) and showed that, despite a repair period, the repair mechanisms were 
ineffective against these lesions.  Cells from the line of invasive ductal breast 
carcinomas were more susceptible to oxidative damage and, also unable to repair it (12).  
The accumulation of unrepaired damage over time will eventually lead to cancer.  
Research is now focused on slowing the progression of this damage to decelerate or 
possibly reverse present cancer, and keeping the damage from accumulating, thus 
preventing cancer from occurring. 
 
Beneficial properties of wine 
Herbal preparations have been extensively used as traditional medicines by most cultures 
for thousands of years.  Various diseases have been treated with crude or refines extracts 
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from many natural sources, and the current widespread use of many nutraceuticals and 
herbal extracts stems from the long history of their therapeutic applications (16).  
Individual natural products from various sources have proven to be highly effective in 
the treatment of many diseases and some of the earliest medicines including aspirin, 
morphine, quinine, digitoxin and pilocarpine were derived from plants (16, 17).   
 
Much research has been conducted in the isolation of phytochemicals from grapes and 
red and white wine and to determine the mechanisms behind the desirable effects they 
have on cancer cells.  Studies have shown that compounds in grapes and wine are health-
promoting and disease-preventing (16) due to their antioxidant and anti-cancer 
properties proven both in vitro and in vivo (11, 18).  They may even decrease prevalence 
of coronary heart disease (14).  Compounds that have been studied and proven to have 
helpful effects are phytochemicals; as they are disease preventing chemicals from a 
plant, antioxidant in function, and polyphenolic in structure due to the multiple phenol 
rings. The bitterness and astringency of wines can be attributed to these polyphenolics 
(9).  It follows then, that red wine has a polyphenolic concentration that is six to seven 
times higher than that of white wine (11).  Also, wine grapes have a higher concentration 
than table grapes (9).  The polyphenol composition in a grape is dependant on the color, 
year, growth site, the degree of maturation and part of the grape.  The seeds, which are 
normally waste from the wine making process, actually contain 5-8% polyphenolics 
including procyanidins and flavonoids such as gallic acid and catechin (9).  Other 
polyphenols in wine are phenolic acids and trihydroxy-stilbenes (resveratrol) (11).   
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These antioxidants in wine are absorbed in the upper gastrointestinal tract after it is 
ingested, and tend to be found in greater concentrations in the liver, heart and kidney 
(11).  One study showed that pure polyphenolics are more effective than in wine (11) but 
even antioxidants in wine extracts, which still contain non-polyphenolic compounds, 
protect against aging, disease and decay.  These polyphenolics have four to five times 
the antioxidant power of Vitamins C and E (9), and it is their structure that gives them 
these properties.  The structure of phytochemicals contains multiple phenol rings and 
hydroxyl (-OH groups) which allow for electron transfer and reduction, as seen below in 
Figure 1 (4, 9).   
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Fig. 1 Chemical Structure of 11 Individual Polyphenols (4). 
 
The structure of these compounds allows them to act as radical scavengers by breaking 
radical chain reactions and putting an end to their detrimental effects (9, 11).  An 
example of this was demonstrated in a study done by Murias, et al.  Hydroxyl groups 
were added to resveratrol and the new compound (3,3',4,4',5,5'-hexahydroxystilbene aka: 
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M8) interacted directly with the mitochondria-the organelle which produces free 
radicals.  This new compound, M8, deactivated the cells’ defense against antioxidants 
(8).  Besides ridding the cell of radicals and allowing the antioxidants to work, 
polyphenols such as ellagic acid and quercetin can act synergistically and induce cell-
death or apoptosis thus killing the cancer cells (17).  Each of these compounds and their 
mechanisms are undergoing much research to be fully understood. 
 
Previous studies 
Many studies have been performed investigating properties of wine and its specific 
compounds.  One potent antioxidant found in grapes and wine that has been widely 
researched is resveratrol.  One study examined the extracts from the skin and seed of a 
particular grape, the muscadine grape.  It was seen that resveratrol inhibited prostate 
cancer cells partly because of its antioxidant capacity but, as it turns out, there is not a 
large amount of resveratrol in the skin compared to the seed.  Somewhat unexpectedly, 
cell growth was decreased by both.  The resveratrol in the seed stopped cells during their 
cycle, confirming many studies done before this, such as the previously discussed 
Murias study.  What was unique was the discovery that a compound in the skin extract 
disrupted Akt activity, causing apoptosis and cell death (5).  In 1999, a study showed 
that resveratrol was the cause of decreased growth, viability and the expression of anti-
apoptotic compounds in leukemia cells.  These cells, which were not strong survivors, 
eventually self destructed because of the antioxidant.  It was also the reason behind 
inhibition at every step in a multi-step carcinogenesis (10).  While studies have shown 
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the positive effects of a compound, it is important to rule out any negative side effects. 
Rats were tested with high enough doses to correspond to 1000 times what an average 
~154 lb person would consume.  While this is not the case of every compound, there 
were no harmful effects due to elevated resveratrol (6). 
 
Another well studied phytochemical is procyanidin.  It has been seen to decrease both 
inflammation and cancer cell growth (9).  Mouse spleen cells were treated with 
procyanidin B4, catechin and gallic acid and had protection from H2O2 at low doses.  
Once the level of protection peaked, damage seen to the cells increased with the 
concentration of catechin (4).  This dose-dependence was also seen in a study done in 
2000.  Polyphenolics from red wine lead to decreased H2O2 susceptibility, cell 
proliferation and tumor arrest both in vitro and in vivo initially.  Higher concentrations, 
as previously seen, did cause a stimulatory effect.  Although this is counter-productive, a 
human would need to chronically ingest red wine for any bioeffective outcomes so the 
risk of ingesting too much of these antioxidants from wine is relatively small (11). 
 
Most studies show the cancer fighting aspects of red wine compounds.  In contrast, 
phenolic compounds piceatonnol (PIC) and myricetin (MYR) that appear in high 
quantities in wine were shown to have estrogen-like activity.  They increased cell growth 
in estrogen-dependant breast cancer cells.  Unlike other studies, this one concluded that 
drinking red wine could actually be a risk factor in post-menopausal women (7). 
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As is often the case, results are incomplete and sometimes contradictory.  One area that 
is lacking is the study of Texas wines, specifically.  Based on the unique climate and 
plant-disease conditions in the state of Texas, only specific grape varieties (Vitis 
vinifera) can be grown.  It is important to identify the compounds and their antioxidant 
properties so these wines may be compared to more popular and more researched 
varieties. 
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CHAPTER II 
METHODS 
 
Phytochemical extracts 
Barrel Port Reserve wine was provided by Messina Hof in Bryan, TX.  Syrah wine was 
provided by Kiepersol Estates in Tyler, TX.  Solid phase extraction was used to extract 
wine polyphenolics.  The wines were diluted 1:5 in nano-pure water then filtered 
through a C-18 Sep-pak filter.  This filter removed water, sugar and other unwanted 
compounds while binding the polyphenolics.  Acidified methanol was used to elute the 
wine extract from the filter into a separate flask.  Once the entire amount of wine had 
been filtered in this way (350mL), the methanol was evaporated using a Büchi rotavapor.  
Approximately 15 mL of the wine/methanol mixture were poured into a small flask and 
rotated in 35°C water while being rotated.  A pump was attached to the rotavapor to 
create a vacuum, thus lowering methanol’s boiling point and allowing it to evaporate.  
Each 15 mL amount of sample was on the rotavapor for 15 minutes to avoid 
decomposing the compounds.  Some methanol remained.  The extract was concentrated 
in a SpeedVac at 43°C for 1.5 hours and stored at -80°C. 
 
Polyphenolic concentration 
The concentration of polyphenolics in each vial of extract, aka: total soluble phenolics, 
was determined by Folin-Ciocalteu’s reagent assay.  The extract was suspended in 5µL 
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DMSO, then further by a factor of 10 with nano-pure water.  Dilutions were made with 
gallic acid to make a standard curve with which to compare the extract sample.  Gallic 
acid concentrations of 1000, 800, 600, 500, 400, 300, 200 and 100 ppm were utilized.  
0.50 mL Folin’s reagent was added to 50µL of each sample (extract and gallic acid), in a 
5mL tube, mixed and left for 3 minutes.  0.50mL Sodium carbonate was then added, 
mixed and solutions were left for 7 minutes.  After such time, 3.95mL nano-pure water 
was added and mixed, and then the samples were kept out of light for one hour.  100µL 
of each sample was added to a well in a 96 well plate and absorbance was measured in a 
plate reader.  Final concentrations were expressed as gallic acid equivalents (GAE).  
These concentrations were used to dilute treatments for assays.  
 
Cell culture 
Non-hormone dependant breast cancer cell line MDA-MB-231 was cultured in 
Dulbecco’s Modified Eagle Medium-High Glucose (DMEM) supplemented with 10% 
fetal bovine serum (FBS) and 1% antibiotic (100,000 U/L penicillin and 100 mg/L 
streptomycin). The cultures were maintained in a humidified atmosphere of 95% air and 
5% CO2 at 37°C.  MDA-MB-231 cells can be seen in Figure 2. 
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Fig. 2 MDA-MB-231 Breast Cancer Cells (19) 
 
ORAC 
The antioxidant capacity of the Syrah and Port wines were determined with an ORAC 
assay as described by Cao (19).  The wine was diluted 200, 150 and 100x with ORAC 
buffer and compared to a standard curve made with different concentrations of Trolox-a 
water soluble form of Vitamin E, a known antioxidant (200, 100, 50, 25, 12.5ppm).  
50µL samples of each dilution were added to wells in a black, clear bottom 96-well 
plate.  100 µL fluorescin dilution (18 µL fluorescin in 50mL ORAC buffer) was added 
to the samples.  330mg ?, a radical, was dissolved in 5mL ORAC buffer to make AARH 
solution just before 50 µL was added to the wells. Fluorescence was read at 37°C in a 
plate reader every 5 minutes for two hours.   
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Cell proliferation 
 To study the effect of the wine extracts on the growth of MDA-MB-231 breast cancer 
cells, 15,000 cells were first seeded into each well of a 24-well plate.  To seed the cells, 
or attach them to the plate to prepare for the assay, medium was removed from the plate 
and the cells were washed with 10 mL buffer PBS to remove any debris and dead cells.  
2mL trypsin were added to the dish and incubated for 4 minutes to detach the cells.  10 
mL FBS was then added to the dish and the plates’ contents were placed in a falcon tube 
and centrifuged for 2 minutes at 1000rpm.  After the FBS was removed a pellet of cells 
remained at the bottom of the tube.  These were re-suspended in 5 mL of DMEM 
containing 2.5% FBS and counted.  Once a solution of the desired concentrations of cells 
was prepared (30,000 cells/well), 0.5mL was added to each well and incubated for 24 
hours.  Plates were treated with different concentrations of wine extract (200, 150, 100, 
75 and 50 mg GAE/mL) and incubated for 72 hours. The control “treatment” contained 
only medium with 0.2% DMSO (as did the other treatments) so to offset any effect it 
may have caused to the cells.  The layout of the plate was as in Figure 3. 
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Fig. 3 Cell Proliferation Plate Layout 
 
After the 72 hour incubation time, cells were detached with 0.25mL of trypsin.  Instead 
of medium, trypsination was arrested with PBS containing 10% FBS.  Contents of each 
well were transferred into a cuvette containing 20mL isotonic solution.  Remaining cells 
were removed with a cell scraper.  After scraping, buffer was added to each well to re-
suspend the newly detached cells.  All contents of each well were recovered and 
transferred into the well’s corresponding cuvette.   The number of cells, and thus cell 
growth, was determined using a cell counter (Beckman Coulter, Fullerton, CA). 
Generation of reactive oxygen species 
Inhibition of ROS generation was measured with the ROS assay.  10,000 MDA-MB-231 
breast cancer cells were seeded in each well of a 96 well plate and incubated for 24 
hours.  Cells were treated with different concentrations (0, 12.5, 25, 50, 75, 100, 150, 
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200 µg GAE/mL) of extract and incubated for 24 hours.  The plate layout is shown in 
Figure 4. 
 
    
 
 
         
 
                Fig. 4 ROS Plate Layout 
 
Oxidative stress was induced with 200µM hydrogen peroxide for 2 hours.  Cells were 
washed with PBS and incubated with 10mM complete name (DCFH-DA) for 15 
minutes. Intensity of fluorescence was read at 37°C after 15 minutes in a microplate 
reader (485 nm excitation and 538 nm).  
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CHAPTER III 
RESULTS 
 
Polyphenolic concentration 
 
Results from the Folin-Ciocalteu’s assay are shown in Table 1. 
Table 1 Polyphenolic Concentration of Wine Extracts 
 
 
 
Extract Vial        Syrah 1             Syrah 2              Port 1             Port 2              Port 3___ 
Equation of      y=1289.2x-       y=1155.5x-       y=1186.6x-      y=1214.6x-     y=121.17x- 
Best Fit Line      172.86               177.49              167.63              134.1              1048.6 
 
R^2                     0.9975               0.9984              0.9926             0.9951            0.9833 
 
Average µg 
GAE/mL_____6347.522          6109.462            4339.762        4663.173          9956.891_ 
 
 
ORAC 
The antioxidant capacities of the wines were determined with an ORAC assay.  The 
standard curve made with different concentrations of Trolox is shown in Figure 5.   
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   Fig. 5 ORAC Standard Curve with Trolox 
 
Values for the wine dilutions were calculated in the equation of the standard curve and 
can be seen in Table 2. 
Table 2 ORAC Results-Antioxidant Capacity for Syrah and Port 
_______________________________________________________________________ 
         _______________Y=2.5054x-1.3789_______________ 
             Average Polyphenolic 
Dilution Factor                  Concentration (µM TE/g)                Antioxidant Capacity____ 
Syrah 
 200x    33.28    81.99422 
 150x    19.53    47.5605 
 100x    9.67    22.8367__________ 
 
Port 
 200x    43.93    108.675 
 150x    24.15    59.1307 
 100x    9.82    23.225___________ 
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These values show that the less concentrated dilutions are relatively equal in antioxidant 
capacity, 22.8 and 22.2uM TE/g respectively. At a dilution of 150x, AOX began to differ 
slightly: 47.6 uM TE/g for the Syrah vs. 59.1 uM TE/g for the Port.  At 200x, the wines 
were significantly different: 81.9 uM TE/g for the Syrah and 108.68 uM TE/g for the 
Port.  The Syrah antioxidant capacity is 80.5% of the Port when diluted 200x. 
Cell proliferation 
Contents of each well were transferred into a cuvette and read twice in the cell counter.  
Results from the Syrah are shown in Table 3. 
Table 3 Cell Proliferation Readings-Syrah 
_______________________________________________________________________ 
TTX [conc]        0               200           150            100 75       50______ 
Row 1          900, 920     410, 408   530, 386   600, 628    582, 548   628, 566 
Row 2          976, 999     441, 488   569, 544    567, 556    567, 543    745, 724 
Row 3          1078, 952   335, 387   434, 473    569, 588    613, 643    654, 647 
Row 4          662, 714     385, 365   566, 540    522, 501    568, 480    613, 579___ 
 
Averages were taken of each concentration and multiplied by the dilution factor of 402.  
These values are the actual number of cells in each well after 72 hours of incubation.  
These values are seen in Figure 4 with error bars too small to be seen.  The percentage of 
cells in each well as compared to the control is seen in Figure 6. 
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                  Fig. 6 Cell Proliferation Syrah Results. A Polyphenolic Concentration vs. Cell # 
 B Polyphenolic Concentration vs. % Cell Proliferation 
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At the lowest concentration, 50 µg GAE/mL, the Syrah wine extract decreased cell 
proliferation to 59% of the control.  Proliferation continued to decrease when higher 
concentrations were used.  At 200 µg GAE/mL, cell proliferation was decreased to 41%.  
The IC50 (concentration at which proliferation is half of the control) is shown to be 
~160 µg GAE/mL.   
Results from the Port are shown in Table 4 and Figure 7. 
 
Table 4 Cell Proliferation Readings-Port 
_______________________________________________________________________ 
TTX [conc]        0               200             150         100         75             50__________ 
Row 1          108, 119        44, 46        74, 65       85, 75         92, 83      101, 81 
Row 2          210, 218        27, 26        82, 91        90, 76        81, 108     73, 73 
Row 3          201, 181        32, 16        80, 73        94, 75        74, 69       68, 85 
Row 4          126, 103        21, 18        73, 79       106, 96       58, 50       97, 93__            _ 
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                  Fig. 7 Cell Proliferation Port Results. A Polyphenolic Concentration vs. Cell #  
                        B Polyphenolic Concentration vs. % Cell Proliferation 
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     Fig . 7 Cont. 
  
 
 
At 50 µg GAE/mL, the Port wine extract decreased cell proliferation to 54% of the 
control, while at the same concentration, the Syrah wine extract decreased cell 
proliferation by 59%.  At 200 µg GAE/mL, the Port wine extract decreased cell 
proliferation to 18% where the same concentration of the Syrah only decreased cell 
growth to 41%.  The IC50 for the Port was ~140 µg GAE/mL.  The large difference in 
the two wines’ IC50s would show that the Port has the greater effect of inhibiting cell 
growth.  This is supported by looking at the percentage of the control’s cell growth at 
200 µg GAE/mL .  18% is significantly lower than 41%. 
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Generation of reactive oxygen species 
Fluorescence values at 15 and 30 minutes are shown below.  Bold and italicized valued 
were discarded as they were dissimilar enough from other values to cause an increase in 
standard deviation and skewed results.  Results from the Syrah are shown in Table 5. 
 
Table 5 ROS Results-Syrah. A Fluorescence after 15 minutes B Fluorescence after 30 minutes 
 
15 
A 
Raw Data           
 1 2 3 4 5 6 7 8 9 10 11 12 
A 6493 36070 14048 20605 31724 25002 30060 32740 30700 - - - 
B 6050 33572 17015 14027 18211 22472 26648 27044 31427 - -   - 
C 6121 41351 18147 12756 19163 20069 30010 27438 34150 - - - 
D 6039 35122 12947 12601 15072 25669 23578 35453 33290 - - - 
E 6068 39617 15359 11820 19664 27748 27312 33130 30633 - - - 
F 6249 40889 11979 17789 15450 25333 25096 28190 23411 - - - 
G 6611 58573 16047 17422 29656 25951 25193 29551 27469 - - - 
H 6293 52416 22023 22187 29469 25913 41029 27674 20638 - - - 
                    
 
 
 
 
30 
 
B 
Raw Data           
 1 2 3 4 5 6 7 8 9 10 11 12 
A 9229 67710 25186 37543 58277 45065 56069 61797 58410 - - - 
B 8660 64095 30746 24523 32838 40549 49013 51755 59828 - - - 
C 8965 79348 33469 22536 35001 36693 57433 51689 65439 - - - 
D 8903 67918 23196 22449 27596 49633 44819 68042 64096 - - - 
E 8905 78397 28476 21543 36679 53727 51537 62387 58456 - - - 
F 9226 79733 21634 33252 28451 48148 47404 54266 44796 - - - 
G 9793 113444 29428 32367 56494 49871 47766 56147 51829 - - - 
H 9326 98564 41155 42247 55813 47463 77865 51575 37420 - - - 
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Fluorescence ranged from 14048 to 58573 when concentrations ranged from 12.5-200 
µg GAE/mL.  These values were used to calculate the “fold” which represents the 
percent fluorescence of cells incubated with treatment versus the control.  Results from 
the Syrah are shown in Figure 8.  
 
       Fig. 8 ROS Syrah Results: Polyphenolic Concentration vs. Fold 
 
Results taken at 15 minutes are most accurate and thus, the values used for analysis.  At 
this time, the generation of Reactive Oxygen Species was decreased to 67.3% of the 
control when treated with 12.5 µg GAE/mL extract.  ROS steadily decreased to 24.3% 
when treated with 150 µg GAE/mL extract and became level as cells treated with the 
200 µg GAE/mL extract had decreased to 23.8%. Similar analysis was done for the Port 
wine.  The data can be seen in Table 6 and Figure 9.  
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Table 6 ROS Results-Port. A Fluorescence after 15 minutes B Fluorescence after 30 minutes   
 
A 
       
Raw Data  
 
Blank 200 ppm 150 ppm 100 ppm 75 ppm 50 ppm 25 ppm 12.5 ppm Ctl 
A 6402 18366 33571 33842 43821 32113 53699 33797 43283 
B 6438 17435 27315 40841 35475 42432 39225 42181 44168 
C 6521 14038 25307 29038 42594 40313 47452 32386 44586 
D 6542 14331 26889 31470 30839 30717 29776 37333 36198 
E 6468 12378 24281 24330 29743 39100 29005 30140 34622 
F 6430 15758 29876 24752 29042 31598 28950 30259 35926 
G 6321 14559 20159 28702 26529 24341 34234 34674 35908 
H 6716 16522 24056 31535 37135 30517 32540 34303 37340 
          
 
B 
       
Raw Data  
 
Blank 200 ppm 150 ppm 100 ppm 75 ppm 50 ppm  25 ppm 12.5 ppm Ctl 
A 8710 31412 56663 57078 74192 54570 91291 58119 76033 
B 8590 29601 46009 69480 60698 72011 67435 74132 78115 
C 8806 23330 42910 49957 73009 69845 83227 57532 78502 
D 8870 23809 45082 53623 53616 53924 51191 65724 63289 
E 8745 20182 40656 40739 51161 67625 50134 51950 60191 
F 8615 26074 50891 41620 50140 53554 49305 52231 61916 
G 8439 23147 32970 47667 44607 40167 57679 58963 60207 
H 9031 26995 39200 51941 61485 50292 53949 56710 63200 
 
 
 
 
 
             
         Fig. 9 ROS Port Results: Polyphenolic Concentration vs. Fold 
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At fifteen minutes, fluorescence ranged from 14083 to 44586 at concentrations ranging 
from 12.5 to 200µg GAE/mL.  At 12.5 µg GAE/mL, the Port wine extract decreased 
fluorescence to 85.8% of the control, where at the same concentration the Syrah wine 
extract caused a decrease to 71.8%.  There was insignificant change until steady 
decrease from 75-200 µg GAE/mL.  At 200 µg GAE/mL there was a drastic decrease in 
fluorescence down to approximately 27.6% of the control where the Syrah decreased 
ROS generation to 27.2%.  At high concentrations, as seen in the Cell Proliferation 
assay, the two wine extracts give similar results.  At the low concentrations, however, 
the Syrah wine extract was more effective at inhibition the generation of reactive oxygen 
species.   
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
 
Summary 
 
It has been shown that phytochemicals found in grapes and red wines are polyphenolic 
compounds that have antioxidant properties.  Their antioxidant properties may prevent 
or decrease the growth of breast cancer.  Polyphenolic compounds were extracted out of 
two Texas red wines (Port and Syrah) and tested on estrogen-receptor negative MDA-
MB-231 breast cancer cells.  The effects of these extracts on cell proliferation and 
generation of reactive oxygen species were tested through various assays.  The ORAC 
results showed both the Syrah and Port wines having similar antioxidant capacity at a 
dilution of 100x, but that when diluted further to 200x, the Syrah’s antioxidant capacity 
was only 80.5% of that of the Port suggesting that the Port wine has a higher antioxidant 
capacity.   
 
The effects of the Syrah and Port wines on cell growth were tested with a Cell 
Proliferation assay.  The proliferation of MD-MBA-231 breast cancer cells was inhibited 
by treatments of the wines in concentrations ranging from 50-200 µg GAE/mL.  When 
treated with the Syrah wine extract, cell proliferation was decreased by 33-59% with 
doses ranging from 50-200 µg GAE/mL.  When treated with the Port wine extract, cell 
proliferation decreased by 45-82% with the same dosing ranges.  The IC50 when treated 
with the Syrah wine extract was approximately 165 µg GAE/mL.  The IC50 when 
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treated with the Port was ~140 µg GAE/mL.  This shows that a smaller concentration of 
the Port wine extract is required for the same inhibition and that the Port wine is 
therefore a more potent antioxidant. 
 
The antioxidant effects of the wine extracts were directly tested on the cells with a 
Reactive Oxygen Species (ROS) assay.  When cells were treated with the Syrah wine 
extract, the generation of ROS decreased from 29-73% with concentrations ranging from 
12.5-200 µg GAE/mL.  When treated with the Port wine extract, the generation of ROS 
decreased from 14-72% with the same concentration ranges.  This shows that higher 
concentrations of these wine extracts have the same effects, but that the Syrah is a more 
effective antioxidant at lower concentrations.  
 
Conclusions  
 
The ORAC results lead to a hypothesis that at low concentrations the Port wine extract 
would have greater antioxidant effects on cell growth and the generation of ROS.  The 
IC50 when the Syrah wine extract was used was ~165 µg GAE/mL where that of the 
Port is ~140.  These values support the hypothesis that the Port wine is a more potent 
antioxidant.   
 
When 12.5 µg GAE/mL treatments of wine extract were used, the generation of ROS 
was inhibited 14% by the Port wine extract and 29% by the Syrah wine extract.  
Contradictory to the results of Cell Proliferation, the inhibition of the generation of ROS 
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was more profound when the Syrah wine extract was used suggesting that the Syrah 
wine is the more potent antioxidant.    
 
To explain this contradiction, an ORAC would be performed on the extracts used in the 
assays to give a more accurate representation of the antioxidant capacity of the extracts 
as opposed to the pure wines.  It is also possible that the mechanism behind the 
antioxidant inhibition of cell growth is different from that of inhibition of ROS.  If taken 
further, this study could include gene expression studies.  Apoptosis biomarkers such a 
p53 and capsase 3 would be investigated in the hopes of suggesting a mechanism behind 
the wines’ growth inhibition effect of MDA-MB-231 cancer cells. 
 
This study, by no means, suggests that drinking of wine will decrease or prevent breast 
cancer.  It is a beginning of new knowledge of the beneficial effects of Texas red wines.  
Further studies would determine the polyphenolic composition of each wine via HPLC.  
Once compounds are isolated, it can be determined exactly which compounds are the 
causes of specific effects by testing them individually.  Synergistic and inhibitory effects 
of the compounds on each other can be determined by testing them once isolated.  On a 
larger scale, clinical trials could be performed to document any effect of drinking these 
wines will have on women currently suffering from this breast cancer.  Much more 
research is needed but with every new study comes new knowledge which brings the 
scientific community closer to preventing and treating breast cancer.   
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